Perspective Therapeutics, Inc. — Director's Dealing 2020

Jun 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2020-06-23

Reporting Person: Cavanagh William (Chief R&D Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-23	Stock Options (right to buy)	$0.61	A	150000	Acquired	2030-06-23	Common Stock (150000)	Direct

Footnotes

F1: 25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested.